Hepion Pharmaceuticals Inc (HEPA)
1.46
-0.06
(-3.95%)
USD |
NASDAQ |
May 03, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Hepion Pharmaceuticals Max Drawdown (5Y): 99.96% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.96% |
March 31, 2024 | 99.96% |
February 29, 2024 | 99.96% |
January 31, 2024 | 99.96% |
December 31, 2023 | 99.96% |
November 30, 2023 | 99.96% |
October 31, 2023 | 99.96% |
September 30, 2023 | 99.96% |
August 31, 2023 | 99.96% |
July 31, 2023 | 99.96% |
June 30, 2023 | 99.96% |
May 31, 2023 | 99.96% |
April 30, 2023 | 99.96% |
March 31, 2023 | 99.96% |
February 28, 2023 | 99.96% |
January 31, 2023 | 99.96% |
December 31, 2022 | 99.96% |
November 30, 2022 | 99.96% |
October 31, 2022 | 99.96% |
September 30, 2022 | 99.96% |
August 31, 2022 | 99.96% |
July 31, 2022 | 99.96% |
June 30, 2022 | 99.96% |
May 31, 2022 | 99.96% |
April 30, 2022 | 99.96% |
Date | Value |
---|---|
March 31, 2022 | 99.96% |
February 28, 2022 | 99.96% |
January 31, 2022 | 99.96% |
December 31, 2021 | 99.96% |
November 30, 2021 | 99.96% |
October 31, 2021 | 99.96% |
September 30, 2021 | 99.96% |
August 31, 2021 | 99.96% |
July 31, 2021 | 99.96% |
June 30, 2021 | 99.96% |
May 31, 2021 | 99.96% |
April 30, 2021 | 99.96% |
March 31, 2021 | 99.96% |
February 28, 2021 | 99.96% |
January 31, 2021 | 99.96% |
December 31, 2020 | 99.96% |
November 30, 2020 | 99.96% |
October 31, 2020 | 99.96% |
September 30, 2020 | 99.96% |
August 31, 2020 | 99.96% |
July 31, 2020 | 99.96% |
June 30, 2020 | 99.96% |
May 31, 2020 | 99.96% |
April 30, 2020 | 99.96% |
March 31, 2020 | 99.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.77%
Minimum
May 2019
99.96%
Maximum
Mar 2020
99.96%
Average
99.96%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Ionis Pharmaceuticals Inc | 70.27% |
Madrigal Pharmaceuticals Inc | 82.20% |
Galectin Therapeutics Inc | 88.76% |
Viking Therapeutics Inc | 89.26% |
89bio Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -83.47 |
Beta (5Y) | 1.723 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 115.1% |
Historical Sharpe Ratio (5Y) | -0.5583 |
Historical Sortino (5Y) | -1.291 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.16% |